EvelynOrlandoMD

PubMed

• ABCL-542 Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder.
  Ford M, Jin Z, Orlando E, Lipsky A, Sawas A, Pro B, Amengual J> ;Clinical lymphoma, myeloma & leukemia.
• 2 citations
  Pilot Trial of Homebound Hematopoietic Cell Transplantation.
  Heather J Landau, Evelyn Orlando, Elizabeth S Rodriguez, Allison Applebaum, Hannah-Rose Mitchell, Jonathan U Peled, Niloufer Khan, Tyler Funnell, David Chung, Michael ...> ;Transplantation and Cellular Therapy. 2022 Dec 1
• 19 citations
  CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.
  Eric L. Smith, Sean M. Devlin, Satyajit Kosuri, Evelyn Orlando, Heather Landau, Alex Lesokhin, David J. Chung, Hani Hassoun, Nikoletta Lendvai, Ola Landgren, Sergio Gi...> ;Biology of Blood and Marrow Transplantation. 2016 Feb 1

Abstracts/Posters

• Carfilzomib plus high dose melphalan conditioning prior to autologous hematopoietic cell transplantation followed by carfilzomib maintenance in patients with relapsed ...
  Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Salzman, D.; Saad, A.; Innis-Shelton, R.; Hamadani, M.; Tamari, R.; Godby, K. N.; Petrovic, V.; Williams, L.; Orlando,..., Blood/ASH 2016, San Diego, CA, 12/2/2016
• Targeting Wilms' tumor 1 protein following CD34-selected allografts by adoptive transfer of donor-derived CTLs in patients with advanced multiple myeloma
  Koehne, G.; Kosuri, S.; Doubrovina, E. S.; Orlando, E.; Giralt, S. A.; Jungbluth, A. A.; O'Reilly, R. J., Biology of Blood and Marrow Transplantation/2016 BMT Tandem Meetings, Honolulu, HI, 2/18/2016